Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Reversal Gives Amicus Renewed Hope For US Oral Fabry Launch

Jul 11 2017

• By Jessica Merrill

pills-tablets-glass-container_69512212_1200

Related Content

Persistence Pays Off For Amicus: Positive Migalastat Data In Hand

Aug 20 2014

Gottlieb Becomes US FDA Commissioner With Immediate Issues Pending

May 10 2017

Oral Fabry Drug Clears CHMP, Amicus Sets Up 'Searchable Mutation' Website

Apr 04 2016

Going Deeper Into Rare Disease, GSK Takes Reins of Amicus Fabry Program

Oct 29 2010

Amicus Eyes Broad Future Label For Migalastat After Huge Filing Setback

Nov 30 2016

Related Companies

Amicus Therapeutics, Inc.

Sanofi

GSK plc

Additional Topics

United States Approvals Rare Diseases Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window